we investigated the safety and efficacy of magnesium hydroxide as a phosphate binder in patients with end-stage renal disease on maintenance hemodialysis , 9 volunteers participated in a four-phase study during which each ingested ( 1 ) no phosphate binders , ( 2 ) magnesium hydroxide ( mg ( oh ) 2 ) alone , ( 3 ) mg ( oh ) 2 and aluminum hydroxide ( a1 ( oh ) 3 ) together and ( 4 ) a1 ( oh ) 3 alone .
C0022661
end-stage renal disease
C0024476
magnesium hydroxide